在患有性结肠炎的埃及患者中,介素-37多态 (rs3811047)
Amr A Zahra1, Yasmeen A Mostafa1, Essam A Hassan2
1Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Molecular biology reports
|July 8, 2025
概括
这项研究发现,在埃及人群中,性结肠炎 (UC) 与更高的Interleukin-37 (IL-37) 血清水平和特定基因变异 (rs3811047 GG基因型) 相关. 这些发现表明IL-37可能在UC病变发生过程中发挥作用.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 胃肠病学 胃肠病学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病 (IBD),涉及免疫失调.
- 确切的UC的原因是未知的,但遗传,环境和免疫因素都涉及.
- 这是首次研究在埃及队列中研究IL-37基因多态 (rs3811047) 与UC有关的研究.
研究的目的:
- 在埃及患有性结肠炎 (UC) 的患者中,探索Interleukin-37 (IL-37) 和IL-37基因多态性 (rs3811047) 血清水平之间的关联.
主要方法:
- 一项涉及40名UC患者和40名健康对照者的病例控制研究.
- 使用ELISA测量了血清IL-37水平.
- 使用实时PCR进行IL-37 rs3811047单核酸多态 (SNP) 基因定型.
主要成果:
- 与对照组相比,UC患者的血清IL-37水平中位数显著更高 (p=0.004).
- 血清IL-37水平与UC疾病严重程度正相关 (部分MAYO得分,p=0.004).
- 在UC患者中,IL-37 rs3811047多态的GG基因型更为普遍,在衰退模型下显示出显著的关联 (p=0.018).
结论:
- 血清IL-37水平升高和IL-37 rs3811047 GG基因型与研究的埃及人群中的性结肠炎有关.
- IL-37可能有助于UC病变和疾病严重程度.
- 需要进一步的研究来阐明IL-37在UC中的确切作用.
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
334
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
334
01:29Drugs for Treatment of Ulcerative Colitis in IBD
242
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
242